Examining the scope and quality of health economic evaluations conducted in Kenya: a systematic review protocol
James Odhiambo Oguta, Catherine Akoth, Caleb Nyakundi, Dorcas Nzilani Kanini, Gilbert Rosana, Alex Adjagba
Corresponding author: James Odhiambo Oguta, Health Economics and Decision Science Institute (HEDSI), Nairobi, Kenya 
Received: 08 Jul 2026 - Accepted: 21 Oct 2026 - Published: 29 Oct 2026
Domain: Health Economics, Health Economics, Health Economics and Financing
Keywords: Cost-effectiveness analysis, cost-utility analysis, decision analytic models, cost, health technology assessment, resource allocation, priority-setting, Kenya
Funding: This work received no specific grant from any funding agency in the public, commercial, or non-profit sectors.
©James Odhiambo Oguta et al. African Journal of Health Economics, Systems and Policy (ISSN: 3136-7062). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: James Odhiambo Oguta et al. Examining the scope and quality of health economic evaluations conducted in Kenya: a systematic review protocol. African Journal of Health Economics, Systems and Policy. 2026;3:3. [doi: 10.11604/ajhesp.2026.3.3.54395]
Available online at: https://www.africanjhesp.org/content/article/3/3/full
Research 
Examining the scope and quality of health economic evaluations conducted in Kenya: a systematic review protocol
Examining the scope and quality of health economic evaluations conducted in Kenya: a systematic review protocol
James Odhiambo Oguta1,2,3,&,
Catherine Akoth1,3,
Caleb Nyakundi1,4,
Dorcas Nzilani Kanini1,
Gilbert Rosana1,
Alex Adjagba2
&Corresponding author
Economic evaluations of healthcare interventions are essential for informing evidence-based priority setting and efficient resource allocation. In Kenya, interest in health technology assessment (HTA) is growing as policymakers seek to strengthen evidence-informed decision-making. The HTA process relies heavily on robust economic evidence; however, little is known about the scope and quality of health economic evaluation studies conducted in Kenya. Therefore, this systematic review aims to map the scope and quality of health economic evaluations conducted in Kenya. This systematic review will follow the PRISMA 2020 guideline and has been registered on PROSPERO (CRD420251132258). A literature search across 10 academic databases: MEDLINE via Ovid, PubMed, Embase, PsycInfo, CINAHL (Cumulative Index of Nursing and Allied Health Literature), EconLit, Web of Science, Scopus, African Index Medicus, and African Journals Online (AJOL) will be performed, with no time limit applied. The review will include studies reporting any type of health economic evaluation conducted in Kenya with the human population. Independent reviewers will screen studies, with conflicts resolved by a senior health economist. We will assess quality using the CHEC Extended checklist, Philips checklists, and CHEERS 2022. We will use a narrative synthesis, combining quantitative and qualitative approaches, to summarise and report findings from the selected studies. Bibliometric analysis will also be performed.
Economic evaluations of healthcare interventions involve comparing different options based on their costs and outcomes [1]. They provide evidence on the costs and benefits associated with health services or programs [2]. Globally, such evaluations have gained increasing importance, as they provide insights into the value of health interventions and support the efficient allocation of limited resources [3]. The increasing importance of health economic evaluations is driven by the substantial costs of health interventions, particularly those associated with medical technologies and pharmaceuticals [4]. This trend has also led most countries to implement formal health economic evaluation procedures, such as Health Technology Assessments (HTA), as standard practices for selecting, prioritizing, and implementing interventions [5].
HTA is a tool used globally to support explicit, evidence-informed priority setting. It involves the systematic evaluation of health technologies, including interventions for health promotion, disease prevention, diagnosis, treatment, or rehabilitation [6]. Despite its importance, the use of HTA in low- and middle-income countries (LMICs) remains limited due to weak links between researchers and policymakers, a lack of policy-relevant studies, and variability in study quality [7]. In many LMICs, including Kenya, there is a growing interest in generating health economic evidence to guide policy [8,9]. Governments have started establishing dedicated HTA or economic evaluation units within ministries of health to support evidence-informed decision-making and healthcare priority setting [10]. However, gaps remain as the value of economic evaluations depends not only on their existence but also on their methodological rigor and transparent reporting [9]. As a result, poor quality studies risk misleading policy decisions and undermining confidence among decision-makers [9,11].
Standardized tools such as the Consensus Health Economic Criteria (CHEC) checklist for methodological quality and the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist for reporting have been developed to address these concerns. Still, their systematic application in LMICs remains limited [12]. In Africa, the number of published economic evaluations has grown in recent years (7). Existing reviews have mainly synthesized evidence on the growth of cost-effectiveness analyses (CEA) [7], the use of health technology assessments [5], and economic evaluations focusing on non-communicable diseases (NCDs) [13,14]. A review assessing the scope and quality of health economic evaluations in Ethiopia highlighted the need to strengthen local technical expertise to conduct high-quality evaluations [15]. While Kenya has made significant strides towards institutionalizing HTA [10], little is known about the scope, quantity, and quality of published economic evaluation studies in Kenya. Therefore, this systematic review aims to assess the methodological standards, reporting quality, and scope of economic evaluation studies carried out in the Kenyan context. The review has the following specific objectives: 1) to identify all health economic evaluation studies in Kenya and their scope; 2) to examine the methodological quality of the selected studies; and 3) to identify health economic evaluation evidence gaps.
We will perform a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines [16]. The review protocol has already been registered with the International Prospective Register of Systematic Reviews (PROSPERO), under registration number CRD420251132258.
Eligibility criteria
We used the PICOS framework (population, interventions, comparators, outcomes, and study design) to develop the inclusion and exclusion criteria (Table 1). Studies conducted in any healthcare setting in Kenya and published in English will be included in the review. Conversely, studies carried out outside Kenya, those conducted in laboratory or research settings without population application, and non-English publications without available translation will be excluded. Moreover, only peer-reviewed published literature will be included regardless of their publication date, while grey literature will be excluded.
Search strategy
We will perform a thorough literature search across 10 major academic databases, including MEDLINE via Ovid, PubMed, Embase, PsycInfo, CINAHL (Cumulative Index of Nursing and Allied Health Literature), EconLit, Web of Science, Scopus, African Index Medicus, and African Journals Online (AJOL). Search terms will be developed from the research question, with minor modifications informed by the database. Only studies focusing on health interventions implemented in Kenya that involve the human population, report economic evaluations, and are published in English will be selected. No publication date restriction will be applied. We will also perform backward and forward citation searching of existing reviews and relevant studies. The search strategy will be developed through a combination of the following key terms, using relevant Boolean operators: {(cost-effectiveness analysis OR cost-benefit analysis OR costs and cost analysis OR incremental cost-effectiveness OR cost utility OR cost minimization) OR (economic evaluation OR economic analysis OR health economics OR pharmacoeconomics) OR (decision analytic models OR Markov model OR decision tree OR decision analysis OR microsimulation OR state transition model OR system dynamic model OR discrete event model)} AND {Kenya}. The detailed MEDLINE via Ovid search strategy is presented in the supplementary material. The search results retrieved from academic databases will be uploaded to Covidence for deduplication and screening. Any other duplicates will be excluded manually at the screening stage.
Study selection
Before the screening stage, the review team will convene to discuss and agree on the inclusion criteria and characteristics of studies to be included. Each study will be independently screened by two reviewers following a two-stage process. First, title and abstract screening of all studies identified during the search will be conducted by JOO and CA (senior health economists), with counter-screening performed by CN, DNK, and RG. Following the completion of title and abstract screening, the team will meet to share experiences and agree on the strategy for the subsequent full-text screening stage. Second, full-text screening of eligible studies will be conducted using the same reviewer configuration: JOO and CA will perform the initial screening, while CN, DNK, and RG will conduct counter-screening. Inter-rater agreement will be measured using Cohen's kappa coefficient at both the title/abstract and full-text screening stages. For full texts not automatically uploaded by Covidence, retrieval will be performed using EndNote, Zotero, or with assistance from a librarian. Throughout both screening stages, conflicts will be resolved by AA, another senior health economist. Finally, the study selection process will be documented in a PRISMA flow diagram, which will illustrate the number of studies excluded at each stage and the reasons for exclusion.
Data extraction
We will create an Excel-based tool to extract the relevant information from the selected studies. Data extraction and verification will be conducted by five reviewers: JOO, CA, CN, DNK, and RG. JOO, CA, and AA will review the data extraction for completeness and accuracy. The extraction tool will cover the following aspects: study characteristics, including study objective, disease areas of focus, intervention, comparator, model architecture (e.g., model type, time horizon, discount rate), and other relevant details. In addition, relevant aspects such as cost currency, outcomes, and conclusions will be extracted. The team will meet throughout the extraction process to discuss and clarify any issues identified.
Risk of bias and quality assessment
The risk of bias for all studies will be assessed using the Consensus Health Economic Criteria (CHEC) Extended checklist [17], with each criterion scored as yes, partly, or no. Besides, the Philips checklist [18] will be used to appraise the model-based studies. Every criterion that is fully met will receive a score of 1 (Y), whereas partially met criteria will receive a score of 0.5 (U). Where the authors have not reported the necessary information for the checklist dimension, they will receive a score of zero (X). Furthermore, the reporting quality will be evaluated using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 guidelines [2]. Each criterion will be scored as "yes" if the necessary information has been reported, "no" if it has not been reported, and "not applicable" if the item does not apply. JOO, CA, AA, DNK, RG, and CN will independently appraise all studies. JOO, CA, CN, and AA will review all quality assessments (for studies in which they were not primarily involved) to ensure the accuracy of the data captured.
Data synthesis and analysis
We will use a narrative synthesis, combining quantitative and qualitative approaches, to summarize and report findings from the selected studies. The findings from the review will be presented as a narrative summary, figures, and tables. To provide a descriptive summary of the evidence base, selected studies will be categorized by disease area, intervention type, and study perspective. The distribution of studies across disease areas will be mapped to highlight areas with limited health economic evidence. Important methodological elements, such as study design, time horizon, costing strategies, discounting, and outcomes, will be compared to identify similarities and differences across the studies. A bibliometric analysis will be performed to describe the trends in authorship and funding of published economic evaluations in Kenya. The analysis will summarize the affiliations of the authors, patterns of authorship, and funding sources (government, international organizations, multiple funders, etc). The results will be presented in graphical summaries to demonstrate the trends over time. Standardized summary tables and figures will be used to display economic results, including incremental costs, health effects, incremental cost-effectiveness ratios (ICERs), and net benefits. Relevant figures will be used to present the results from the CHEC, Philips, and CHEERS checklists. We will also examine how uncertainty, heterogeneity, and transferability were addressed across the different studies. This synthesis will offer an extensive understanding of the scope and quality of health economic evaluations performed in Kenya and will also identify future research gaps.
Patient and public involvement
Neither the patients nor the public were directly involved in the design of this systematic review. This study will synthesise published literature and not involve primary data collection from participants.
Ethics and dissemination
This research does not require ethics approval because the study is a planned systematic review of published literature. Findings will be presented at health economic conferences and published in a peer-reviewed journal. Results will also be disseminated to key stakeholders and decision-makers, including the Ministry of Health (MOH), HTA agencies, and development partners such as the World Health Organization (WHO), United Nations Children's Fund (UNICEF), among others.
This review will be conducted in accordance with the PRISMA 2020 guidelines to ensure transparency and rigour [16]. The eligibility criteria for study inclusion and exclusion are detailed in the methods section. To the best of our knowledge, informed by a comprehensive literature search, this is the first review to assess the scope, methodological standards, and quality of health economic evaluations in Kenya.
As Kenya is in the process of institutionalizing health technology assessment (HTA), this review will provide critical evidence on trends in economic evaluations to guide policymakers on cost-effective health interventions, informing resource allocation and other key policy decisions. The broad scope and inclusion criteria focused on all health economic evaluations conducted in Kenya will benefit policymakers across diverse health departments. Furthermore, the extensive quality assessment using the CHEC, Philips, and CHEERS checklists will help identify areas for improvement in subsequent economic evaluations. Kenya has an increasing burden of NCDs alongside the high burden of communicable diseases, necessitating robust economic evaluations to inform priority setting decisions [19,20]. Understanding the scope and quality of existing economic evaluations is a critical first step towards strengthening the use of health economic evidence in Kenya's decision-making processes.
One limitation of our review is the restriction of our search to studies published in English, excluding non-English studies. However, since English is the official language in Kenya, it is highly unlikely that we will miss important studies in languages other than English. This review will focus exclusively on peer-reviewed literature and will not include grey literature. The diversity in economic evaluation methods and disease areas will limit comparability across the studies. Nevertheless, this review will provide comprehensive, up-to-date evidence on the scope, quality, and results of published economic evaluations in Kenya to inform evidence-based priority setting.
The authors declare no competing interests.
James Odhiambo Oguta and Catherine Akoth conceptualised the study and developed the protocol. Caleb Nyakundi, Dorcas Nzilani Kanini, and Gilbert Rosana contributed to the search strategy and data extraction plan. Alex Adjagba reviewed the protocol for methodological rigour. All authors have read and approved the final version of this publication.
Table 1: study eligibility criteria
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford university press; 2015. Google Scholar
- Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Health Services Research. 2022 Jan 27;22(1):114. PubMed | Google Scholar
- Mosadeghrad AM, Jaafaripooyan E, Zamandi M. Economic Evaluation of Health Interventions: A Critical Review. Iran J Public Health. 2022 Oct;51(10):2159-70. PubMed | Google Scholar
- Dang A, Likhar N, Alok U. Importance of Economic Evaluation in Health Care: An Indian Perspective. Value Health Reg Issues. 2016 May;9:78-83. PubMed | Google Scholar
- Hollingworth S, Fenny AP, Yu SY, Ruiz F, Chalkidou K. Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis. Cost Eff Resour Alloc. 2021 Jul 7;19(1):39. PubMed | Google Scholar
- Chalkidou K, Glassman A, Marten R, Vega J, Teerawattananon Y, Tritasavit N et al. Priority-setting for achieving universal health coverage. Bull World Health Organ. 2016 Jun 1;94(6):462-7. PubMed | Google Scholar
- Panzer AD, Emerson JG, D'Cruz B, Patel A, Dabak S, Isaranuwatchai W et al. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020 Aug;29(8):94554. PubMed | Google Scholar
- Phommachanh S, Sittimart M, Ananthakrishnan A, Vongsack S, Soysouvanh S, Ashley EA et al. Situation analysis of evidence-informed health decision-making in Lao PDR: the case of health technology assessment. Lancet Reg Health West Pac. 2025 Apr 9;57:10153 PubMed | Google Scholar
- Oguta JO, Wambiya E, Breeze P, Akparibo R, Akoth C, Toweet SK et al. Not quite yet: stakeholder perspectives on health economic evidence use in non-communicable disease priority setting in Kenya. Cost Effectiveness and Resource Allocation. 2026 Sep 21. Google Scholar
- Mbau R, Vassall A, Gilson L, Barasa E. Factors influencing institutionalization of health technology assessment in Kenya. BMC Health Serv Res. 2023 Jun 22;23(1):681. PubMed | Google Scholar
- Catalá-López F, Ridao M, Alonso-Arroyo A, García-Altés A, Cameron C, González-Bermejo D et al. The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review. Syst Rev. 2016 Jan 7;5:6. PubMed | Google Scholar
- Adam T, Hsu J, de Savigny D, Lavis JN, Røttingen JA, Bennett S. Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions. Health Policy Plan. 2012 Oct;27 Suppl 4:iv9-19. PubMed | Google Scholar
- Hollingworth SA, Leaupepe GA, Nonvignon J, Fenny AP, Odame EA, Ruiz F. Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources. Cost Eff Resour Alloc. 2023 Aug 28;21(1):57. PubMed | Google Scholar
- Oguta JO, Breeze P, Wambiya E, Kibe P, Akoth C, Otieno P et al. Application of decision analytic modelling to cardiovascular disease prevention in Sub-Saharan Africa: a systematic review. Commun Med. 2025 Feb 22;5(1):46. PubMed | Google Scholar
- Erku D, Mersha AG, Ali EE, Gebretekle GB, Wubishet BL, Kassie GM et al. A systematic review of scope and quality of health economic evaluations conducted in Ethiopia. Health Policy Plan. 2022 Feb 21;37(4):514-22. PubMed | Google Scholar
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. PubMed | Google Scholar
- Odnoletkova I. CHEC-Extended: A tool for the quality assessment of economic evaluations of healthcare interventions. 2014. Google Scholar
- Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. PubMed | Google Scholar
- Zimmermann MR, Vodicka E, Babigumira JB, Okech T, Mugo N, Sakr S et al. Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya. Cost Eff Resour Alloc. 2017 Jul 14;15:13. PubMed | Google Scholar
- Worrall E, Were V, Matope A, Gama E, Olewe J, Mwambi D et al. Coverage outcomes (effects), costs, cost-effectiveness, and equity of two combinations of long-lasting insecticidal net (LLIN) distribution channels in Kenya: a two-arm study under operational conditions. BMC Public Health. 2020 Dec 7;20(1):1870. PubMed | Google Scholar


